Clinical Trial Update: Mild-Intensity Whole Body Hyperthermia (WBH) for Major Depressive Disorder [Phase 2]

View source ↗

Summary

Phase 2 trial of mild-intensity whole body hyperthermia for major depressive disorder has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Mild-Intensity Whole Body Hyperthermia

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Major Depressive Disorder | Phase 2 | Status: SUSPENDED